rootsanalysis has been a member of Article Pole since 2020-05-06. Their last visit to Article Pole was on 2020-10-16 08:59:02.

This user has not submitted a user bio yet

Latest Activity For rootsanalysis

Latest Articles From rootsanalysis

Latest Forum Threads From rootsanalysis

Several Investors have Realized the Opportunity within this Upcoming Segment (Antibody Drug Conjugates) of Targeted Cancer Therapeutics Industry Peptide Therapeutics: Contract API Manufacturing Market-Impact of COVID-19 Pandemic Peptide Therapeutics: Contract API Manufacturing Market- Current and Future Market Opportunity Across Key Market Segments Peptide Therapeutics: Contract API Manufacturing Market-Outsourcing versus In-House Manufacturing, Decision Making Peptide Therapeutics: Contract API Manufacturing Market- Global, Annual Demand and Capacity Geographical Estimation of the Peptide API Contract Manufacturing Market Peptide Therapeutics: An Analysis on the Clinical Trials Peptide Therapeutics: Contract API Manufacturing Market- Recent Partnerships, Expansions and Innovative Technologies Peptide Therapeutics: Contract API Manufacturing Market- Likely Evolution of the Different Regions Peptide Therapeutics: Contract API Manufacturing-Current Market Landscape An Overview of Peptide Therapeutics and its Contract Manufacturing Market Case Study: Several stakeholders have engaged the services of CMOs to cater to the complexities related to manufacturing and assembly of large volume wearable injectors Large Volume Wearable Injectors: Current and Future Market Opportunities Across Key Market Segments Status of Patents that have been Filed / Granted in the Large Volume Wearable Injectors Domain related to Pharmaceutical and Biopharmaceutical Industry The Increasing Traction in the Field of Large Volume Wearable Injectors is Reflected in the Partnership Activity Focused on the delivery of both insulin and non-insulin drugs, Involving Stakeholders across the world Large Volume Wearable Injectors Market – Market Landscape (non-insulin delivery devices, insulin delivery devices and Drug Device combinations) Large Volume Wearable Injectors – A Breakthrough in the field of self-injection devices and the Growing Future Potential China Biopharmaceutical Contract Manufacturing Market: Current and Future Market Opportunity Across Key Market Segments Big Pharma Biopharmaceutical Manufacturing Initiatives in China China Biopharmaceutical Contract Manufacturing Market: Installed Capacity Regional Capability of Different Regions Within China Clinical Trials of Biological Interventions Conducted / Underway in China In Order to Cope up with the Current and Future Market Demand, Chinese Biopharmaceutical Contract Manufacturers are Actively Investing and Collaborating to Expanding their Existing Infrastructure and Capabilities China Contract Manufacturing Market - Current Market Landscape China Biopharmaceutical Contract Manufacturing Market - Gaining Traction in the Pharmaceutical Industry Prefilled Syringes Market is Likely to Grow at a CAGR of More than 4% Prefilled Syringes: Technological Advances To Sustain Future Growth, Drug Developers are Considering such Devices for Product Life Cycle Management and are Likely to Evaluate Novel Drug-Device Combinations To Sustain Future Growth, Drug Developers are Considering such Devices for Product Life Cycle Management and are Likely to Evaluate Novel Drug-Device Combinations The Prefilled Syringes Market is Likely to Grow at a Steady Pace over the Coming Years The Prefilled Syringes Market is also Characterized by the Presence of Many Contract Service Providers, Spread Across the World, Offering Fill / Finish Services in Prefilled Syringes Multiple Prefilled Syringe Combination Products are Available in the Market, While Several Are Under Development, for the Treatment of a Variety of Disease Indications Across the World Prefilled Syringes and Regulatory Landscape In Order to Gain a Competitive Edge in the Market, Prefilled Syringe Manufacturers are Actively Engaged in Developing Patient Friendly Products, with Improved Safety Features and Solutions Demand for Prefilled Syringes Continues to Grow, Given the Numerous Benefits they Offer Over Conventional Injectable Drug Delivery Systems Determining the Strength Weaknesses, Opportunities and Threats related to RNAi Therapeutics RNAi Therapeutics Market- Current and Future Growth Opportunities within the Domain A Comparative Overview, on Adoption of Lucrative Promotional Strategies for the Marketed RNAi Therapeutics with respect to Oligonucleotide Therapeutics To Advance the Developments in RNAi Therapeutics, the Developers are actively Seeking for Fundraiser Opportunities RNAi Therapeutics Developers have Undertaken Several Partnership Initiatives, to Strengthen Their Activities in the Domain RNAi Therapeutics Market - Status Filed / Granted Patents RNAi Therapeutics Market- RNAi Therapeutics in Clinical Trials Liquid Biopsy and Other Non-Invasive Cancer Diagnostics: Current and Future Market Opportunities Across Key Market Segments The Growing Interest in The Field of Non-Invasive Cancer Diagnostics Can be Reflected in the Partnership Activity with Deals Inked in the Recent Past Focused on a Diverse Range of Tumor Markers, Involving Both International and Indigenous Stakeholders Over Time, Big Pharma Players Have Initiated Product Development Programs, Having Invested Significant Capital, Time and Effort, on Non-Invasive Diagnostic Solutions for Use Across Different Oncological Indications Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market – Market Landscape Non-Invasive Cancer Diagnostics – Potential Alternatives to Cost-Intensive and Painful Tissue Biopsies Oligonucleotide Manufacturing Market: Key Growth Drivers and Roadblocks Oligonucleotide Manufacturing Market: Global, Annual Demand In Order to Cope up with the Current and Future Market Demand, Oligonucleotide Manufacturers are Actively Investing and Collaborating to Expanding their Existing Infrastructure and Capabilities Oligonucleotide Manufacturing Market - Likely Evolution of the Different Regions Pandemic Like Never Before – Continuous Manufacturing to the Rescue Neoantigen Targeted Therapies – A Potential Weapon in the Fight against Cancer Neoantigen Targeted Therapies Pave the Way to Personalized Anti-cancer Therapy How COVID-19 Poses a Sharp Challenge on China Biopharmaceutical Contract Manufacturing Market? Response to COVID-19 Pandemic with Oligonucleotides Growing Oligonucleotide-based Drugs Pipeline Escalates Manufacturing Demand Growing Pipeline of Microbiome-based Live Biotherapeutics Fuels the Manufacturing Demand ASCO 2020: AstraZeneca Presents a Game-Changer in Lung Cancer Prefilled Syringes Fill/Finish Services Market – Present Scenario and the Growing Future Potential

Latest Forum Posts From rootsanalysis

Over the years, monetary assistance from angel investors, venture capitalists and funding schemes of  . . . . . The pharmaceutical sector is one of the few industries that has been relatively less  . . . . . Outsourcing provides a platform for establishing strategic collaborations, which eventually helps players to augment  . . . . . Given the growing preference for outsourcing in the pharmaceutical industry, it is imperative for  . . . . . The annual, global demand for therapeutic peptide APIs is estimated to be 2,145  . . . . . An informed capability assessment of different geographies, such as North America, Europe and Asia  . . . . . The number and geographical distribution of clinical trials are important indicators of both the  . . . . . During our research, we came across several partnerships and collaborations that have been inked  . . . . . Several industry players have established   . . . . . Over the years, the peptide therapeutics domain has evolved significantly. In fact, till date  . . . . . The introduction of insulin therapy in the 1920s, for the treatment of diabetes, marked  . . . . . Rising complexities related to handling and administration of novel / advanced therapeutic options, have caused  . . . . . Currently, three drug-device combinations, namely Herceptin® SC Injector (Roche),  Neulasta® (pegfilgrastim) OnPro  . . . . . With the increase in popularity of self-injection devices, several industry stakeholders have attempted  . . . . . Stakeholders in the pharmaceutical and medical-device development industry are known to adopt a  . . . . . Given the multifaceted advantages of   . . . . . Over the past few years, there has been an evident shift towards the self  . . . . . Over the years,   . . . . . Several big pharmaceutical players have carried out multiple biopharmaceuticals focused initiatives, including acquisitions, facility  . . . . . Majority share (53%) of the   . . . . . The key parameters that, we believe, are likely to have an influence on the  . . . . . The number and geographical distribution of clinical trials are important indicators of both the  . . . . . In the pharmaceutical industry, stakeholders are known to adopt a variety partnerships and expansion  . . . . . Currently, over 35 CMOs / CDMOs in China claim to offer manufacturing services for biopharmaceuticals  . . . . . The current biopharmaceuticals market is characterized by high quality standards and a rapidly growing  . . . . . The demand for prefilled syringes has increased rapidly over the past several years, driven  . . . . . The prefilled syringes available in the market have undergone various technological advancements in features  . . . . . According to the Centers for Disease Control and Prevention, diabetes, migraine and cancer are  . . . . . According to the Centers for Disease Control and Prevention, diabetes, migraine and cancer are  . . . . . The burden of chronic diseases has increased over the last few decades, across all  . . . . . The filling of sterile drugs into the appropriate primary containers (in this case  . . . . . According to experts in the healthcare industry, one in three adults are estimated to  . . . . . Prefilled syringes were first launched in the 1970s and since then have undergone considerable  . . . . . Prefilled syringes have been in market for over two decades now and have witness  . . . . .   The first successful use of prefilled syringes can be traced back to  . . . . . RNA interference is a post transcriptional gene silencing process that is believed to have  . . . . . In 2019, the projected market is worth USD 160 million. We expect the overall  . . . . . Drug developers heavily rely on a number of broadcasting channels, which include direct to  . . . . . Over the years, monetary assistance from angel investors, venture capitalists, and funding schemes of  . . . . . In the recent past, several companies have collaborated with other industry players / research institutes  . . . . . Over the past decade, industry stakeholders have been extensively working towards improving the treatment  . . . . . The number and geographical distribution of clinical trials are important indicators of both the  . . . . . Given the invasive nature of tissue biopsies, there is a significant unmet need for  . . . . . As the number of players involved in the development of   . . . . . Over the years, various well-established big pharmaceutical players have marked their presence in  . . . . . Given the multifaceted advantages of   . . . . . Cancer is known to be one of the leading causes of death worldwide. In  . . . . . Over the years, contract / custom service providers have evolved significantly, acquiring specialized capabilities and  . . . . . At present, eight oligonucleotide-based drugs have been approved, while over 200 product candidates  . . . . . In the pharmaceutical industry, stakeholders are known to adopt a variety partnerships and expansion  . . . . . Several industry players have established oligonucleotide manufacturing facilities across the world. During our research  . . . . . The   . . . . . Cancer – one of the most feared and dreaded diseases. It is known to be  . . . . . Neoantigen Targeted Therapies Pave the Way to Personalized Anti-cancer Therapy  . . . . . China, epicenter of the COVID-19, is the world’s second largest   . . . . . Never before, scientists say, the universal community of researchers have put a halt to  . . . . . As therapeutic agents, oligonucleotides  . . . . . Live biotherapeutics are fragile bacteria, which require ideal conditions of heat, moisture and pH  . . . . . While the ASCO 2020 presentation was virtual this year, the phase III results from  . . . . . The filling of sterile drugs into prefilled syringes (and other  . . . . .